Oral gefitinib plus methotrexate is not clinically superior to methotrexate for tubal ectopic pregnancy.

Published Date: 17 Feb 2023

A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...

Read Full News

Latest News

J&J Reaches Sweeping Talc Deal That Could End Decade Of Litigation

(This July 27 story has been republished, with no change to text)

US Judge Says Biden-era Restrictions on Prescribing Abortion Drug Are Unlawful

A federal judge in Virginia has ruled that it was illegal for former President Joe Biden's administration to require doctors and pharmacies to be ⁠specially certified to...

Severe Preeclampsia Mapped in Affected Tissues in New Study

Severe preeclampsia appears to involve tissues far beyond the placenta, according to a new study that provides one of the most detailed cellular maps of the condition to date.

Indigenous Canadians Mistreated During Childbirth

Nearly two thirds of Indigenous Canadians surveyed report experiencing mistreatment and disrespect during pregnancy and childbirth.

Ischemic Placental Disease Tied to Postpartum Brain Risks

Pregnancies complicated by ischemic placental disease are associated with a higher risk for hospital admissions for brain disorders in the year after delivery, a study finds.

In Maternal Health Deserts, Pharmacists Are Bridging Gaps

To address high rates of maternal and infant mortality and morbidity, pharmacists in Mississippi are stepping in to provide care and connect women with obstetric care.

Todays Updates

Trial Challenges Indefinite Maintenance for Multiple Myeloma

A randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Todays Updates

Trial Challenges Indefinite Maintenance for Multiple Myeloma

A randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Latest News

(This July 27 story has been republished, with no change to text)

A federal judge in Virginia has ruled that it was illegal for former President Joe Biden's administration to require doctors and pharmacies to be ⁠specially certified to...

Severe preeclampsia appears to involve tissues far beyond the placenta, according to a new study that provides one of the most detailed cellular maps of the condition to date.

Nearly two thirds of Indigenous Canadians surveyed report experiencing mistreatment and disrespect during pregnancy and childbirth.

Pregnancies complicated by ischemic placental disease are associated with a higher risk for hospital admissions for brain disorders in the year after delivery, a study finds.

To address high rates of maternal and infant mortality and morbidity, pharmacists in Mississippi are stepping in to provide care and connect women with obstetric care.

News All Time

Medicaid Funding Resumes for Planned Parenthood After Halting for Most of a Year

Some services are returning but others may not

Hospital Under Investigation; 4,000 Nurses Strike; Fentanyl Makers Pivot to Peptides

Health news and commentary gathered by MedPage Today staff

Translating Risk Into Tailored Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

Translating Risk Into Tailored Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

Advancing TNBC Care: Clinical Insights and Effective Application of Emerging Treatment Strategies Across Lines of Therapy

Advancing TNBC Care: Clinical Insights and Effective Application of Emerging Treatment Strategies Across Lines of Therapy

Molecular Matters: Next-Gen Sequencing, Liquid Biopsy, and the Future of ctDNA Applications

Molecular Matters: Next-Gen Sequencing, Liquid Biopsy, and the Future of ctDNA Applications

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

Maternal RSV Vaccine Linked to Lower Risk of Infant Hospitalization

"This is real protection, and it really applies to all comers," researcher says

What Vitamin K Shot Refusals Are Really Telling Us

We can't fact-check our way out of a trust crisis

Genomic Test May Spare More Patients With Node-Positive Breast Cancer From Chemo

Experts discuss Prosigna-guided treatment decisions in high-risk early disease

Optimizing Perioperative Therapy in Triple-Negative Breast Cancer

The treatment landscape for these patients is evolving

Tailoring Treatment for Triple-Negative Breast Cancer in Older Patients

"Most of the time we undertreat," says expert

ACOG Makes Vaccine Recommendations for the First Time

A look at how the recommendations differ from the CDC

They Told Families to 'Eat Real Food.' Now They May Cut the Produce Benefit.

To make America healthy, produce in a poor child's diet should be the last thing to go

Upcoming Billing Change Could Make Pregnancy Pricier

ACOG says the change is crucial to accurately reflect the care ob/gyns currently provide

Trump's 22 Medical Specialists; Infectious Hot Tub; Ending Postpartum Hemorrhage

Health news and commentary gathered by MedPage Today staff

Drinking in Pregnancy on the Rise, CDC Data Show

Expert urges public health campaigns to share the dangers of alcohol use in pregnancy

Recommended News For You

FDA Approves Subcutaneous Isatuximab for MM Indications

Prostate cancer screening program beneficial in top decile of polygenic risk score

Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer

automated, precise reporting for clonality testing using NGS.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

When Should Immunocompromised Individuals Receive a COVID Booster?

PSA Screening May Modestly Curb Prostate Cancer Deaths

Recommended Articles For You

What Is Carboxyhemoglobin And How Can It Affect Your Health? 

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer 

Sorafenib: Understanding the science behind a powerful cancer drug  

Frontiers in Cancer Therapeutics: U.S. Oncology Trials and Drug Discovery Trends 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

DBT Reduced Suicide Attempts in Adolescents with Bipolar Disorder.

2.

Prostate cancer therapies: AI-based image analysis detects early organ damage

3.

New imaging solution could help improve survival for patients with recurring prostate cancer

4.

Early, virtual palliative care feasible for advanced lung cancer

5.

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

1.

Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation

2.

Iron Deficiency Anemia: Modern Diagnostic Approaches and Personalized Treatment Strategies

3.

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor

4.

Understanding Drug-Induced Cardiotoxicity: Mechanisms, Impact, and Future Directions

5.

The Unseen Threat: Uncovering the Risks of Pancoast Tumor

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

2.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

3.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

5.

Navigating the Complexities of Ph Negative ALL - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot